Financhill
Buy
59

NSANY Quote, Financials, Valuation and Earnings

Last price:
$5.68
Seasonality move :
3.08%
Day range:
$5.55 - $5.70
52-week range:
$4.41 - $8.79
Dividend yield:
4.49%
P/E ratio:
4.58x
P/S ratio:
0.13x
P/B ratio:
0.26x
Volume:
445K
Avg. volume:
716.2K
1-year change:
-27.92%
Market cap:
$10.4B
Revenue:
$87.9B
EPS (TTM):
$1.24
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue $90.9B $74.2B $75B $78.5B $87.9B
Revenue Growth (YoY) -12.94% -18.4% 1.18% 4.57% 12.02%
 
Cost of Revenues $77.7B $64.3B $63B $65.8B $73.6B
Gross Profit $13.2B $9.9B $12.1B $12.7B $14.3B
Gross Profit Margin 14.54% 13.37% 16.07% 16.17% 16.29%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $5.3B $4.2B $3.5B $3.5B $3.8B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $13.6B $11.3B $9.9B $9.9B $10.4B
Operating Income -$372.3M -$1.4B $2.2B $2.8B $3.9B
 
Net Interest Expenses -- $220.5M $347.4M $176M $100.6M
EBT. Incl. Unusual Items -$5.3B -$3.2B $3.4B $3B $4.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $857.1M $873.5M $1.3B $1.2B $1B
Net Income to Company -$5.3B -$3.2B $3.4B $3B $4.2B
 
Minority Interest in Earnings -$46.4M -$158.2M -$207M -$142.9M -$158.7M
Net Income to Common Excl Extra Items -$6.2B -$4.2B $1.9B $1.6B $3B
 
Basic EPS (Cont. Ops) -$3.16 -$2.16 $0.98 $0.84 $1.53
Diluted EPS (Cont. Ops) -$3.16 -$2.16 $0.98 $0.84 $1.53
Weighted Average Basic Share $2B $2B $2B $2B $1.9B
Weighted Average Diluted Share $2B $2B $2B $2B $1.9B
 
EBITDA $2.4B $3.3B $9.7B $8.3B $9.1B
EBIT -$5.2B -$2.9B $3.9B $3.4B $4.7B
 
Revenue (Reported) $90.9B $74.2B $75B $78.5B $87.9B
Operating Income (Reported) -$372.3M -$1.4B $2.2B $2.8B $3.9B
Operating Income (Adjusted) -$5.2B -$2.9B $3.9B $3.4B $4.7B
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $10.9B $18.3B $16.5B $21.3B $19.2B
Revenue Growth (YoY) -49.45% 68.14% -10.1% 28.91% -9.54%
 
Cost of Revenues $10B $15.3B $13.9B $17.6B $16.7B
Gross Profit $916.5M $3B $2.6B $3.6B $2.6B
Gross Profit Margin 8.4% 16.53% 15.93% 17.06% 13.38%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $661.8M $570.7M $581.6M $735.8M $896.1M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.3B $2.3B $2.1B $2.7B $2.6B
Operating Income -$1.4B $691.4M $500.9M $937.2M $6.4M
 
Net Interest Expenses -- $100.7M $64.5M $23.9M $31.2M
EBT. Incl. Unusual Items -$2.8B $1.6B $815.1M $941.9M $419M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$188.7M $446.2M $410.8M $133.9M $193.7M
Net Income to Company -$2.8B $1.6B $815.1M $941.9M --
 
Minority Interest in Earnings -$12M -$65.5M -$40.6M -$39.3M -$42.1M
Net Income to Common Excl Extra Items -$2.7B $1B $363.6M $768.7M $183.2M
 
Basic EPS (Cont. Ops) -$1.36 $0.53 $0.19 $0.39 $0.10
Diluted EPS (Cont. Ops) -$1.36 $0.53 $0.19 $0.39 $0.10
Weighted Average Basic Share $2B $2B $2B $2B $1.8B
Weighted Average Diluted Share $2B $2B $2B $2B $1.8B
 
EBITDA -$1.1B $3.2B $2.2B $2.2B $1.6B
EBIT -$2.8B $1.7B $930.7M $1.1B $542.7M
 
Revenue (Reported) $10.9B $18.3B $16.5B $21.3B $19.2B
Operating Income (Reported) -$1.4B $691.4M $500.9M $937.2M $6.4M
Operating Income (Adjusted) -$2.8B $1.7B $930.7M $1.1B $542.7M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $80.2B $81.8B $73.1B $83.1B $85.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $69.2B $69.7B $61.4B $69.5B $72.5B
Gross Profit $11.1B $12.1B $11.6B $13.7B $13.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $4.9B $4.2B $3.5B $3.7B $3.9B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $12.9B $11.3B $9.6B $10.4B $10.3B
Operating Income -$1.8B $726M $2B $3.2B $3B
 
Net Interest Expenses -- $331.4M $311.6M $135.1M $108.1M
EBT. Incl. Unusual Items -$8.3B $1.2B $2.7B $3.1B $3.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $516.5M $1.5B $1.3B $918.4M $1.1B
Net Income to Company -$8.3B $1.2B $2.7B $3.1B --
 
Minority Interest in Earnings -$23.5M -$212.3M -$182.8M -$141M -$160.9M
Net Income to Common Excl Extra Items -$8.9B -$497.9M $1.3B $2.1B $2.4B
 
Basic EPS (Cont. Ops) -$4.53 -$0.25 $0.65 $1.05 $1.24
Diluted EPS (Cont. Ops) -$4.53 -$0.25 $0.65 $1.05 $1.24
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$936.2M $7.7B $8.7B $8.3B $8.5B
EBIT -$8.2B $1.7B $3.2B $3.6B $4.2B
 
Revenue (Reported) $80.2B $81.8B $73.1B $83.1B $85.7B
Operating Income (Reported) -$1.8B $726M $2B $3.2B $3B
Operating Income (Adjusted) -$8.2B $1.7B $3.2B $3.6B $4.2B
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $10.9B $18.3B $16.5B $21.3B $19.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $10B $15.3B $13.9B $17.6B $16.7B
Gross Profit $916.5M $3B $2.6B $3.6B $2.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $661.8M $570.7M $581.6M $735.8M $896.1M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.3B $2.3B $2.1B $2.7B $2.6B
Operating Income -$1.4B $691.4M $500.9M $937.2M $6.4M
 
Net Interest Expenses -- $100.7M $64.5M $23.9M $31.2M
EBT. Incl. Unusual Items -$2.8B $1.6B $815.1M $941.9M $419M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$188.7M $446.2M $410.8M $133.9M $193.7M
Net Income to Company -$2.8B $1.6B $815.1M $941.9M --
 
Minority Interest in Earnings -$12M -$65.5M -$40.6M -$39.3M -$42.1M
Net Income to Common Excl Extra Items -$2.7B $1B $363.6M $768.7M $183.2M
 
Basic EPS (Cont. Ops) -$1.36 $0.53 $0.19 $0.39 $0.10
Diluted EPS (Cont. Ops) -$1.36 $0.53 $0.19 $0.39 $0.10
Weighted Average Basic Share $2B $2B $2B $2B $1.8B
Weighted Average Diluted Share $2B $2B $2B $2B $1.8B
 
EBITDA -$1.1B $3.2B $2.2B $2.2B $1.6B
EBIT -$2.8B $1.7B $930.7M $1.1B $542.7M
 
Revenue (Reported) $10.9B $18.3B $16.5B $21.3B $19.2B
Operating Income (Reported) -$1.4B $691.4M $500.9M $937.2M $6.4M
Operating Income (Adjusted) -$2.8B $1.7B $930.7M $1.1B $542.7M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents $12.8B $17B $11.7B $13.5B $12.5B
Short Term Investments $2.4B $1.5B $3B $1.6B $1.6B
Accounts Receivable, Net $3.3B $4.7B $3.3B $4.4B $4.2B
Inventory $12.4B $10.3B $11.2B $12.8B $13.6B
Prepaid Expenses -- -- -- -- --
Other Current Assets $5.5B $4B $3.9B $4.4B $4.2B
Total Current Assets $98.8B $93.8B $84.5B $85.3B $85.1B
 
Property Plant And Equipment $41.8B $39.7B $35.8B $32.8B $31.5B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $2.2B $2.4B $2.4B $1.8B $1.9B
Total Assets $157.1B $149.1B $134.1B $132.1B $131.2B
 
Accounts Payable $12.6B $13.6B $11.4B $14.4B $14.7B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $329.1M $394.7M $396.5M $375.7M $309.1M
Other Current Liabilities $8.1B $7.1B $6.6B $6.7B $6.7B
Total Current Liabilities $74.6B $61B $50.3B $50.8B $45.8B
 
Long-Term Debt $29.1B $38.3B $33.1B $30.6B $34.8B
Capital Leases -- -- -- -- --
Total Liabilities $116.1B $109.8B $92.9B $89.9B $88.4B
 
Common Stock $5.6B $5.5B $5B $4.5B $4B
Other Common Equity Adj -- -- -- -- --
Common Equity $37.6B $35.8B $37.5B $38.5B $39.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $3.3B $3.6B $3.7B $3.6B $3.2B
Total Equity $40.9B $39.3B $41.2B $42.1B $42.8B
 
Total Liabilities and Equity $157.1B $149.1B $134.1B $132.1B $131.2B
Cash and Short Terms $15.2B $18.4B $14.7B $15.1B $14.1B
Total Debt $72.2B $67.8B $57.3B $51.8B $50.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $20.1B $12.1B $9.8B $9.3B $9.1B
Short Term Investments $3.3B $1.5B $1.5B $1.6B $1.5B
Accounts Receivable, Net $3.6B $2.8B $2.4B $2.8B $2.9B
Inventory $10.6B $11.8B $12.7B $13.7B $14.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $4.7B $5.8B $4.3B $4.3B $4.3B
Total Current Assets $98.6B $86.6B $77.5B $81B $83.5B
 
Property Plant And Equipment $40.7B $38.2B $30.9B $31.4B $31.9B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $5.4B $4.1B $4B $3.8B $4.8B
Total Assets $155.8B $139.2B $121.8B $126.1B $132.3B
 
Accounts Payable $10.7B $10.2B $11.7B $13.4B $13.3B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $386.4M $331.5M $357.9M $276.6M $313.9M
Other Current Liabilities $7.3B $6.7B $6.1B $6.2B $7B
Total Current Liabilities $63.3B $54.3B $45.6B $45.1B $46.6B
 
Long-Term Debt $42.2B $34.2B $28.7B $30.9B $34.1B
Capital Leases -- -- -- -- --
Total Liabilities $118B $98.4B $83.1B $83.8B $88.3B
 
Common Stock $5.7B $5.4B $4.2B $4.1B $4.2B
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $3.3B $3.6B $3.4B $3.4B $3.6B
Total Equity $37.8B $40.8B $38.7B $42.3B $44B
 
Total Liabilities and Equity $155.8B $139.2B $121.8B $126.1B $132.3B
Cash and Short Terms $23.5B $13.7B $11.3B $10.9B $10.6B
Total Debt $77.4B $62.9B $49.1B $48.2B --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -$5.3B -$3.2B $3.4B $3B $4.2B
Depreciation & Amoritzation $7.6B $6.2B $5.7B $4.8B $4.4B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $7.4B $6B $5.5B $397.9M -$1.9B
Change in Inventories -$1.1B $2.7B -$111.3M -$1.5B -$777.2M
Cash From Operations $10.9B $12.5B $7.5B $9B $6.7B
 
Capital Expenditures $10.3B $7.7B $7.2B $6B $8.7B
Cash Acquisitions $7.5M $84.8M $1.4M -$261.4M $47.9M
Cash From Investing -$6.5B -$3.5B -$1.3B -$3.3B -$5.6B
 
Dividends Paid (Ex Special Dividend) -$1.4B -- -- -$144.9M -$407.2M
Special Dividend Paid
Long-Term Debt Issued $16.7B $33.1B $14.3B $11.6B $16.7B
Long-Term Debt Repaid -$21.1B -$28.6B -$24.6B -$14.8B -$13.2B
Repurchase of Common Stock -$18.4K -- -$17.8K -$41M -$831.4M
Other Financing Activities $134.1M $18M $47.3M $12.2M $169.9M
Cash From Financing -$1.4B -$6B -$9.7B -$5B -$911.6M
 
Beginning Cash (CF) $12.5B $15.5B $18.1B $13.3B $14B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $3B $3B -$3.5B $765.8M $115.6M
Ending Cash (CF) $15.1B $19.2B $16B $14.9B $14.7B
 
Levered Free Cash Flow $653.3M $4.7B $343M $3B -$2.1B
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -$6.3B -$87.4M $543.2M $1.1B $1.2B
Depreciation & Amoritzation $1.6B $1.1B $1.2B $1.1B $967.3M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $1.2B -$867.3M -$606.7M -$1.7B -$1.3B
Change in Inventories $424.7M $1.3B -$132.4M $870.6M $869M
Cash From Operations $3.5B $3.3B $2.2B $3.6B $3.2B
 
Capital Expenditures $2.3B $2.1B $1.6B $2.3B $2.5B
Cash Acquisitions -$8.6M -$1.3M $17.1K -$5M $1.1M
Cash From Investing -$1.7B -$1.4B $649.2M -$1.9B -$1.8B
 
Dividends Paid (Ex Special Dividend) -$660.3K -- -- -$6.1M -$9.2M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $4.3B $5.2B $3.5B $5.8B $7.9B
Long-Term Debt Repaid -$6.1B -$9.6B -$7.4B -$3.5B -$4.1B
Repurchase of Common Stock -$10 -- -$9K -$1.7M -$18.9M
Other Financing Activities $9.3M -$270.8K $588.4K $514.3K --
Cash From Financing $545.8M -$3.9B -$3.6B $862M $891.3M
 
Beginning Cash (CF) $13B $20.7B $15.7B $11.9B $11.9B
Foreign Exchange Rate Adjustment -$228M $775M $747.7M -$187.4M $163.5M
Additions / Reductions $2.3B -$2B -$745.1M $2.6B $2.3B
Ending Cash (CF) $15.1B $19.2B $16B $14.9B $14.7B
 
Levered Free Cash Flow $1.2B $1.1B $559.9M $1.4B $746.1M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -$8.3B $1.2B $2.7B $3.1B --
Depreciation & Amoritzation $7.3B $6B $5.5B $4.7B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $9.1B $4.9B $3.7B -$1.6B --
Change in Inventories $1.5B $1.5B -$1.1B -$962.4M --
Cash From Operations $8.6B $14.2B $7B $8.7B $4B
 
Capital Expenditures $8.8B $8.7B $6.1B $7B $6.5B
Cash Acquisitions $7.5M $86.2M -$12.8M -$248.6M $47.9M
Cash From Investing -$7.2B -$2.3B -$1.1B -$4.5B --
 
Dividends Paid (Ex Special Dividend) -$371.5M -- -$151.1M -$279.4M -$121.7M
Special Dividend Paid
Long-Term Debt Issued $21.1B $27.5B $13.1B $12.5B --
Long-Term Debt Repaid -$19.9B -$27B -$26.1B -$12.2B --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $37.4M -- -- -- --
Cash From Financing $1.1B -$8.8B -$11.4B -$1.7B --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.5B $3.1B -$5.5B $2.6B --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$192.3M $5.5B $857.3M $1.7B --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$3.2B $3.4B $3B $4.2B --
Depreciation & Amoritzation $6.2B $5.7B $4.8B $4.4B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $6B $5.5B $397.9M -$1.9B --
Change in Inventories $2.7B -$111.3M -$1.5B -$777.2M --
Cash From Operations $12.5B $7.5B $9B $6.7B --
 
Capital Expenditures $7.7B $7.2B $6B $8.7B --
Cash Acquisitions $84.8M $1.4M -$261.4M $47.9M --
Cash From Investing -$3.5B -$1.3B -$3.3B -$5.6B --
 
Dividends Paid (Ex Special Dividend) -- -- -$144.9M -$407.2M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $33.1B $14.3B $11.6B $16.7B --
Long-Term Debt Repaid -$28.6B -$24.6B -$14.8B -$13.2B --
Repurchase of Common Stock -- -$17.8K -$41M -$831.4M --
Other Financing Activities $18M $47.3M $12.2M -- --
Cash From Financing -$6B -$9.7B -$5B -$911.6M --
 
Beginning Cash (CF) $72.9B $65.6B $48.9B $51.5B --
Foreign Exchange Rate Adjustment $725.7M $1.3B $832.6M $659.3M --
Additions / Reductions $3B -$3.5B $765.8M $115.6M --
Ending Cash (CF) $76.8B $63B $49.9B $51.5B --
 
Levered Free Cash Flow $4.7B $343M $3B -$2.1B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock